Stay updated on Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page
- Check5 days agoChange DetectedA banner announces NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence.” The site revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check33 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the record and showing the site's standard error layout.SummaryDifference17%

- Check40 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0, indicating a backend/software update to the page rendering.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, signaling a new version of the page was published. This represents a version-tracking update rather than a substantive change to the displayed content.SummaryDifference0.0%

- Check61 days agoChange DetectedThe study identifiers now include '2017 ( U.S. NIH Grant/Contract )', alongside the existing ANB019-003 and the EudraCT number (2017-004022-15).SummaryDifference0.0%

Stay in the know with updates to Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.